AWAKN Life Sciences Launches Clinical Research Division

Ryan Allway September 11th, 2020 Psychedelics AWAKN Life Sciences Inc (“AWAKN”), the European psychedelic assisted psychotherapy company, today announces the launch of its Commercial Clinical Research Division. AWAKN’s purpose is […]

Clinical Endocannibinoid Deficiency Syndrome 

Clinical Endocannibinoid Deficiency What is Endocannibinoid Deficiency Syndrome? To start, a syndrome is a concurrence of symptoms that happen on a regular basis. In other words, they always happen and […]